share_log

Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(8.67%),Deep Track Biotechnology Master Fund, Ltd.(8.67%), etc.

Feb 14, 2023 08:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more